To access this element change to forms mode OFF
Grant Award View - GA201506
Predictive biomarkers of response, resistance and toxicity with...
GA ID:
GA201506
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,342,072.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Predictive biomarkers of response, resistance and toxicity with immunotherapy in melanoma
Purpose:
Immunotherapy has activity across many cancers, none more so than melanoma where approximately half the patients with metastatic disease may be cured. Half the patients do not benefit, however, and the drugs can cause toxicity and are expensive. At present, clinicians have little ability to predict who will and will not respond to therapy or get toxicity, nor the mechanisms underlying this. Improving this understanding will improve patient outcomes and reduce costs to the healthcare system.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009476
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA